$29.02▾ 1.39%
End-of-day close · 2026-09-01
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
Not enough data yet
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
Not enough data yet
Not enough revenue history to measure growth.
Leverage
Not enough data yet
More coming: dilution / share-count creep.
✦ The read
Beam Therapeutics Inc.'s earnings-quality signal is not available yet.
Key numbers
Recent news
Sentiment · last 30 days1 article
1 bullish0 neutral0 bearish
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just BoughtBeam Therapeutics to Participate in Upcoming September 2026 Investor Conferences
Cathie Wood Is Buying This Up-and-Coming Biotech Stock. Should You Follow Her Lead?Gene Editing Therapeutics: Transforming Biopharmaceuticals with 12.5% CAGR Growth Forecast